BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8096663)

  • 1. Nonhuman primate response to murine and humanized monoclonal antibodies.
    Delmonico FL; Cosimi AB
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):65-7. PubMed ID: 8096663
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of monoclonal antibodies on primate allograft rejection.
    Conti DJ; Cosimi AB
    Crit Rev Immunol; 1990; 10(2):113-30. PubMed ID: 1981679
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress in monoclonal antibodies in clinical transplantation.
    Cosimi AB
    Transplant Proc; 1994 Aug; 26(4):1943-4. PubMed ID: 7915057
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of a primate model of renal transplantation in the development of new monoclonal antibodies.
    Shapiro ME; Reed MH; Strom TB; Carpenter CB; Milford EL; Kirkman RL
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):58-60. PubMed ID: 2816938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does exposure to swine leukocyte antigens after pig-to-nonhuman primate xenotransplantation provoke antibodies that cross-react with human leukocyte antigens?
    Key T; Schuurman HJ; Taylor CJ
    Xenotransplantation; 2004 Sep; 11(5):452-6. PubMed ID: 15303982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical application of monoclonal antibody therapies in renal transplantation.
    Dhanireddy KK; Xu H; Mannon RB; Hale DA; Kirk AD
    Expert Opin Emerg Drugs; 2004 May; 9(1):23-37. PubMed ID: 15155134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies against intercellular adhesion molecule 1 prolong cardiac allograft survival in cynomolgus monkeys.
    Flavin T; Ivens K; Rothlein R; Faanes R; Clayberger C; Billingham M; Starnes VA
    Transplant Proc; 1991 Feb; 23(1 Pt 1):533-4. PubMed ID: 1671305
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional consequences of anti-ICAM-1 (CD54) in cynomolgus monkeys with renal allografts.
    Wee SL; Cosimi AB; Preffer FI; Rothlein R; Faanes R; Conti D; Colvin RB
    Transplant Proc; 1991 Feb; 23(1 Pt 1):279-80. PubMed ID: 1671301
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppression using a monoclonal antibody to ICAM-1 in murine allotransplantation.
    Guymer RH; Mandel TE
    Transplant Proc; 1992 Feb; 24(1):218-9. PubMed ID: 1347183
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficient killing of CD22+ tumor cells by a humanized diabody-RNase fusion protein.
    Krauss J; Arndt MA; Vu BK; Newton DL; Seeber S; Rybak SM
    Biochem Biophys Res Commun; 2005 Jun; 331(2):595-602. PubMed ID: 15850802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination of humanized monoclonal antibody rhuMAb2H7 in cynomolgus monkey serum using a Generic Immunoglobulin Pharmacokinetic (GRIP) assay.
    Yang J; Ng C; Lowman H; Chestnut R; Schofield C; Sandlund B; Ernst J; Bennett G; Quarmby V
    J Immunol Methods; 2008 Jun; 335(1-2):8-20. PubMed ID: 18402977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1.
    Werther WA; Gonzalez TN; O'Connor SJ; McCabe S; Chan B; Hotaling T; Champe M; Fox JA; Jardieu PM; Berman PW; Presta LG
    J Immunol; 1996 Dec; 157(11):4986-95. PubMed ID: 8943405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humanized Mik beta 1, a humanized antibody to the IL-2 receptor beta-chain that acts synergistically with humanized anti-TAC.
    Hakimi J; Ha VC; Lin P; Campbell E; Gately MK; Tsudo M; Payne PW; Waldmann TA; Grant AJ; Tsien WH
    J Immunol; 1993 Jul; 151(2):1075-85. PubMed ID: 8335891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation of primate renal allografts with anti-Tac monoclonal antibody.
    Reed MH; Shapiro ME; Strom TB; Milford EL; Carpenter CB; Letvin NL; Waldmann TA; Kirkman RL
    Curr Surg; 1988; 45(1):28-30. PubMed ID: 3126026
    [No Abstract]   [Full Text] [Related]  

  • 15. The anti-idiotypic response by cynomolgus monkeys to humanized anti-Tac is primarily directed to complementarity-determining regions H1, H2, and L3.
    Schneider WP; Glaser SM; Kondas JA; Hakimi J
    J Immunol; 1993 Apr; 150(7):3086-90. PubMed ID: 8454876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OKT3 antibody response study: comparative testing of human antimouse antibody.
    Kimball JA; Norman DJ; Shield CF; Schroeder TJ; Lisi P; Garovoy M; O'Connell JB; Stuart F; McDiarmid SV; Wall W
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):74-6. PubMed ID: 8465432
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of a monoclonal antibody directed against interleukin 2 receptor in recipients of kidney allografts.
    Soulillou JP; Le Mauff B; Cantarovich D; Hourmant M; Vie H; Jacques Y
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):84-6. PubMed ID: 3051598
    [No Abstract]   [Full Text] [Related]  

  • 18. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OKT4A (a murine IgG2a anti-CD4 monoclonal antibody) in human organ transplantation: pharmacokinetics and peripheral pharmacodynamics.
    Henell KR; Cheever JM; Kimball JA; Lye WC; Munar MY; Misiti J; Vitow C; Norman DJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):800-1. PubMed ID: 8438489
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
    Stubenrauch K; Wessels U; Lenz H
    J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.